SILO
Silo Pharma·NASDAQ
--
--(--)
--
--(--)
SILO fundamentals
During Q4 2025, Silo Pharma (SILO) reported revenue of 18.03K, a YoY change of 0.00%. Net income was -881.53K, a YoY change of 49.06%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 17.19K -- | 18.03K -- | 18.02K -- | 18.03K -- | 18.03K +4.88% | 18.02K -0.01% | 18.02K -- | 18.03K -- | 18.03K -- | 18.02K -- | 18.02K -- | 18.03K -- | 18.03K -- | 18.02K -- | 18.02K -- | 18.03K -- | 18.03K -- | 18.02K -- | 18.02K -- | 18.03K -- | 72.10K -- |
Sales and Services Revenue | 17.19K -- | 18.03K -- | 18.02K -- | 18.03K -- | 18.03K +4.88% | 18.02K -0.01% | 18.02K -- | 18.03K -- | 18.03K -- | 18.02K -- | 18.02K -- | 18.03K -- | 18.03K -- | 18.02K -- | 18.02K -- | 18.03K -- | 18.03K -- | 18.02K -- | 18.02K -- | 18.03K -- | 72.10K -- |
Cost of Revenue | 625 -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K +133.60% | 1.46K -0.07% | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 20.69K +1317.89% | 20.69K +1317.05% | 44.30K -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | 5.00K -- | -- -- | -- -- | -- -- | 5.84K +16.67% | -- -- | -- -- | 1.46K -- | 1.46K -74.99% | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 1.46K -- | 20.69K +1317.89% | 20.69K +1317.05% | 44.30K -- |
Gross Profit | 16.56K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K +0.02% | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | 16.57K -- | -2.66K -116.07% | -2.66K -116.08% | 27.81K -- |
Operating Expenses | 917.70K -- | 453.42K -- | 480.51K -- | 958.98K -- | 543.83K -40.74% | 510.85K +12.67% | 965.72K +100.98% | 1.67M +74.51% | 820.05K +50.79% | 1.13M +121.50% | 789.96K -18.20% | 1.18M -29.47% | 896.08K +9.27% | 1.02M -9.92% | 1.03M +29.96% | 1.83M +55.04% | 1.11M +23.95% | 1.27M +24.11% | 1.15M +11.90% | 823.78K -54.98% | 4.35M -- |
Selling, General and Administrative Expenses | 183.32K -- | 100.65K -- | 79.56K -- | 1.79M -- | 164.01K -10.54% | 126.13K +25.32% | 156.87K +97.17% | 1.85M +3.44% | 227.22K +38.55% | 408.29K +223.70% | 589.55K +275.82% | 916.14K -50.60% | 577.84K +154.30% | 240.05K -41.21% | 509.07K -13.65% | 754.20K -17.68% | 516.73K -10.58% | 248.28K +3.43% | 605.19K +18.88% | 477.86K -36.64% | 1.85M -- |
Research and Development Expenses | 48.60K -- | 98.85K -- | 70.51K -- | 475.95K -- | 170.28K +250.35% | 105.68K +6.91% | 375.80K +432.94% | 634.68K +33.35% | 202.91K +19.17% | 130.72K +23.70% | 174.50K -53.57% | 336.96K -46.91% | 318.24K +56.84% | 392.82K +200.51% | 517.55K +196.60% | 1.08M +219.24% | 593.96K +86.64% | 717.25K +82.59% | 543.62K +5.04% | 306.00K -71.55% | 2.16M -- |
Loss on Bad Debts | -- -- | -- -- | -- -- | -148.50K -- | -- -- | -- -- | -- -- | -20.00K +86.53% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 39.92K -- | -- -- |
Other Operating Expenses | 685.78K -- | 253.92K -- | 330.43K -- | -1.16M -- | 209.54K -69.44% | 279.05K +9.89% | 433.06K +31.06% | -795.75K +31.48% | 389.92K +86.08% | 592.55K +112.35% | 25.91K -94.02% | -72.81K +90.85% | -- -- | 386.46K -34.78% | -- -- | -- -- | -- -- | 299.59K -22.48% | -- -- | -- -- | -- -- |
Operating Income | -901.14K -- | -436.85K -- | -463.94K -- | -942.42K -- | -527.26K +41.49% | -494.29K -13.15% | -949.15K -104.58% | -1.66M -75.82% | -803.49K -52.39% | -1.11M -125.58% | -773.40K +18.52% | -1.16M +29.77% | -879.51K -9.46% | -1.00M +10.06% | -1.01M -30.60% | -1.81M -55.82% | -1.09M -24.40% | -1.25M -24.51% | -1.15M -14.00% | -826.44K +54.42% | -4.32M -- |
Non-Operating Income (Loss) | 37.40K -- | 48.04K -- | 6.96M -- | -114.63K -- | -75.65K -302.27% | -164.12K -441.61% | -34.09K -100.49% | -5.87K +94.88% | -102.91K -36.04% | 102.03K +162.17% | 113.24K +432.15% | 112.15K +2009.55% | 77.85K +175.64% | 71.00K -30.42% | 81.24K -28.26% | 82.73K -26.23% | 62.68K -19.48% | 44.26K -37.66% | 41.03K -49.50% | -55.09K -166.59% | 92.88K -- |
Income (Loss) from Affiliates | 38.75K -- | 30.00K -- | 6.96M -- | -7.02M -- | -161.80K -517.54% | -59.51K -298.37% | -35.07K -100.50% | 361.08K +105.14% | 390 +100.24% | -3.51K +94.11% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | 6.91M -- | -- -- | -- -- | -- -- | -435.90K -106.31% | -- -- | -- -- | -1.86K -- | 4.04K +100.93% | 234 -- | -1.26K -- | 0 +100.00% | 0 -100.00% | 2.92K +1148.72% | 989 +178.55% | 0 -- | 0 -- | 3.91K -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -67.85K -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -8.70K -- | -2.93K -- | -2.62K -- | 0 -- | 0 +100.00% | 0 +100.00% | 0 +100.00% | 0 -- | -- -- |
Other Non-Operating Income (Loss) | -- -- | 19.08K -- | 0 -- | 0 -- | 85.73K -- | -104.98K -650.17% | 0 -- | 283 -- | -166.03K -293.66% | -2.18K +97.92% | 0 -- | 0 -100.00% | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -2.69K -- | 2.90K -- | -- -- |
Net Interest Expense | 1.35K -- | 1.04K -- | 483 -- | -1.05K -- | -415 -130.76% | -377 -136.25% | -981 -303.11% | -68.67K -6464.53% | -62.73K -15016.39% | -107.72K -28473.21% | -115.10K -11632.93% | -108.11K -57.44% | -86.31K -37.58% | -75.18K +30.21% | -83.86K +27.14% | -82.73K +23.47% | -59.76K +30.76% | -43.27K +42.45% | -43.72K +47.87% | -9.86K +88.08% | -156.61K -- |
Interest Expense | -- -- | -- -- | -- -- | 3.04K -- | -- -- | -- -- | -- -- | 2.20K -27.57% | 1.66K -- | 1.86K -- | 1.08K -- | 273 -87.59% | 1.87K +12.99% | 1.86K -0.21% | 1.08K +0.28% | 274 +0.37% | 2.07K +10.48% | 1.65K -11.35% | 886 -18.04% | 32.70K +11835.04% | 37.30K -- |
Interest Income | -- -- | -- -- | -- -- | 1.21K -- | 415 -- | 377 -- | 981 -- | 70.86K +5756.53% | 64.39K +15415.18% | 109.58K +28967.37% | 116.18K +11742.81% | 108.38K +52.94% | 88.18K +36.95% | 77.04K -29.70% | 84.94K -26.89% | 83.01K -23.41% | 61.83K -29.88% | 44.92K -41.70% | 44.60K -47.49% | 42.56K -48.72% | 193.91K -- |
Pretax Income From Continuing Operations | -863.74K -- | -388.81K -- | 6.49M -- | -1.06M -- | -602.91K +30.20% | -658.40K -69.34% | -983.25K -115.15% | -1.66M -57.31% | -906.40K -50.34% | -1.01M -53.85% | -660.16K +32.86% | -1.05M +36.76% | -801.67K +11.55% | -931.78K +8.01% | -928.81K -40.70% | -1.73M -64.57% | -1.03M -28.66% | -1.20M -29.25% | -1.11M -19.55% | -881.53K +49.06% | -4.23M -- |
Income Tax Expense | -- -- | -- -- | 19.13K -- | 5.74K -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income from Discontinued Operations | -66.97K -- | -73.18K -- | -87.32K -- | -25.90K -- | -1.16K +98.26% | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -69.60K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -930.70K -- | -461.99K -- | 6.39M -- | -1.09M -- | -604.07K +35.10% | -658.40K -42.51% | -983.25K -115.40% | -1.66M -52.74% | -906.40K -50.05% | -1.01M -53.85% | -660.16K +32.86% | -1.12M +32.57% | -801.67K +11.55% | -931.78K +8.01% | -928.81K -40.70% | -1.73M -54.36% | -1.03M -28.66% | -1.20M -29.25% | -1.11M -19.55% | -881.53K +49.06% | -4.23M -- |
Net Income Attributable to Owners of the Company | -930.70K -- | -461.99K -- | 6.39M -- | -1.09M -- | -604.07K +35.10% | -658.40K -42.51% | -983.25K -115.40% | -1.66M -52.74% | -906.40K -50.05% | -1.01M -53.85% | -660.16K +32.86% | -1.12M +32.57% | -801.67K +11.55% | -931.78K +8.01% | -928.81K -40.70% | -1.73M -54.36% | -1.03M -28.66% | -1.20M -29.25% | -1.11M -19.55% | -881.53K +49.06% | -4.23M -- |
Preferred Stock Dividends | 1.40M -- | -- -- | -- -- | -1.40M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Adjustments | -- -- | -- -- | -- -- | 1.40M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -2.33M -- | -461.99K -- | 6.39M -- | -1.09M -- | -604.07K +74.13% | -658.40K -42.51% | -983.25K -115.40% | -1.66M -52.74% | -906.40K -50.05% | -1.01M -53.85% | -660.16K +32.86% | -1.12M +32.57% | -801.67K +11.55% | -931.78K +8.01% | -928.81K -40.70% | -1.73M -54.36% | -1.03M -28.66% | -1.20M -29.25% | -1.11M -19.55% | -881.53K +49.06% | -4.23M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 5.24K -- | -8.52K -- | 2.56K -- | -5.50K -- | 32.33K +517.12% | -18.08K -112.18% | 11.77K +360.16% | -17.38K -215.73% | 8.29K -74.37% | -1.14K +93.69% | 1.78K -84.87% | -5.52K +68.25% | 3.41K -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | -604.07K -- | -658.40K -- | -983.25K -- | -1.66M -- | -901.16K -49.18% | -1.02M -55.14% | -657.60K +33.12% | -1.13M +32.24% | -769.34K +14.63% | -949.86K +7.01% | -917.04K -39.45% | -1.75M -55.15% | -1.02M -32.99% | -1.21M -26.91% | -1.11M -20.89% | -887.05K +49.25% | -4.22M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -604.07K -- | -658.40K -- | -983.25K -- | -1.66M -- | -901.16K -49.18% | -1.02M -55.14% | -657.60K +33.12% | -1.13M +32.24% | -769.34K +14.63% | -949.86K +7.01% | -917.04K -39.45% | -1.75M -55.15% | -1.02M -32.99% | -1.21M -26.91% | -1.11M -20.89% | -887.05K +49.25% | -4.22M -- |
Basic EPS | -0.03 -- | 0 -- | 3.2 -- | -- -- | -0.31 -933.33% | -0.33 -- | -0.49 -115.31% | -0.53 -- | -0.29 +6.45% | -0.32 +3.03% | -0.21 +57.14% | -0.39 +26.42% | -0.28 +3.45% | -0.31 +3.13% | -0.22 -4.76% | -0.39 -- | -0.23 +17.86% | -0.19 +38.71% | -0.12 +45.45% | -0.07 +82.05% | -0.61 -- |
Basic EPS from Continuing Operations | -0.03 -- | 0 -- | 3.24 -- | -- -- | -0.31 -933.33% | -0.33 -- | -0.49 -115.12% | -- -- | -- -- | -- -- | -0.21 +57.14% | -- -- | -0.28 -- | -0.31 -- | -0.22 -4.76% | -- -- | -0.23 +17.86% | -0.19 +38.71% | -0.12 +45.45% | -- -- | -- -- |
Basic EPS from Discontinued Operations | 0 -- | 0 -- | -0.04 -- | -- -- | 0 -- | 0 -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | -0.03 -- | 0 -- | 3.16 -- | -- -- | -0.31 -933.33% | -0.33 -- | -0.49 -115.51% | -- -- | -0.29 +6.45% | -0.32 +3.03% | -0.21 +57.14% | -- -- | -0.28 +3.45% | -0.31 +3.13% | -0.22 -4.76% | -- -- | -0.23 +17.86% | -0.19 +38.71% | -0.12 +45.45% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -0.03 -- | 0 -- | 3.2 -- | -- -- | -0.31 -933.33% | -0.33 -- | -0.49 -115.31% | -- -- | -- -- | -- -- | -0.21 +57.14% | -- -- | -0.28 -- | -0.31 -- | -0.22 -4.76% | -- -- | -0.23 +17.86% | -0.19 +38.71% | -0.12 +45.45% | -- -- | -- -- |
Diluted EPS from Discontinued Operations | 0 -- | 0 -- | -0.04 -- | -- -- | 0 -- | 0 -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What does Silo Pharma do and what are its main business segments?What factors drove the changes in Silo Pharma's revenue and profit?What is Silo Pharma's gross profit margin?What is Silo Pharma's latest dividend and current dividend yield?What is the market's earnings forecast for Silo Pharma next quarter?What is the revenue and EPS growth rate for Silo Pharma year over year?What were the key takeaways from Silo Pharma's earnings call?What guidance did Silo Pharma's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
